glp-1 obesity drug news october 21 2025 New Pill Foundayo (Orforglipron) Gets FDA Approval for Myths & Facts: GLP-1 Drugs

K.et al (2022)

Fecal microbiota transplantation forClostridium difficileInfection: systematic review and meta-analysis

Six compounds were selected for their demonstrated reactivity toward macromolecules, including allicin (ALL), ajoene (AJO), and their metabolites such as S-allyl-L-cysteine (SAC), diallyl disulfide (DADS), diallyl sulfide (DAS), and allyl methyl sulfide (AMS) (Fig

In multiple sclerosis models, GLP-1 receptor activation reduces pathogenic Th1 and Th17 cell activity, inhibits microglial activation (the brain equivalent of macrophage inflammation), and may enhance remyelination processes

Free from toxic agents and bleaching ingredients Relieves dullness, post-breakout marks (PIH) and other pigmentary conditions Suitable for daily use